Conclusion  The present study revealed that plasma concentration of PAX, 5-HTTLPR genotype, -1019C/G 5-HT1A genotype, PAS score at baseline, and adverse effects may influence the therapeutic response to PAX in patients with PD.




Content Type Journal ArticlePages 1-9DOI 10.1007/s00228-011-1073-9Authors
Shin Ishiguro, Department of Psychiatry, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu-machi, Shimotsuga, Tochigi 321â

More...